Cyclin-dependent kinase 9 inhibition protects cartilage from the catabolic effects of proinflammatory cytokines.

Authors:
Ratna Kumari
Ratna Kumari
Lawrence J. Ellison Musculoskeletal Research Center
Sacramento | United States
Blaine A Christiansen
Blaine A Christiansen
Washington University in St. Louis
Prof. Dominik R Haudenschild, Ph.D.
Prof. Dominik R Haudenschild, Ph.D.
University of California Davis Medical Center
Professor
Arthritis Research
Sacramento, CA | United States

Arthritis Rheumatol 2014 Jun;66(6):1537-46

University of California Davis, Sacramento, California.

Objective: Cyclin-dependent kinase 9 (CDK-9) controls the activation of primary inflammatory response genes. The purpose of this study was to determine whether CDK-9 inhibition protects cartilage from the catabolic effects of proinflammatory cytokines.

Methods: Human chondrocytes were challenged with different proinflammatory stimuli (interleukin-1β [IL-1β], lipopolysaccharides, and tumor necrosis factor α) in the presence or absence of either the CDK-9 inhibitor flavopiridol or small interfering RNA (siRNA). The expression of messenger RNA (mRNA) for inflammatory mediator genes, catabolic genes, and anabolic genes were determined by real-time quantitative reverse transcription-polymerase chain reaction (qRT-PCR) analysis. Cartilage explants were incubated for 6 days with IL-1β in the presence or absence of flavopiridol. Cartilage matrix degradation was assessed by the release of glycosaminoglycan (GAG) and cleaved type II collagen (COL2A) peptides.

Results: CDK-9 inhibition by flavopiridol or knockdown by siRNA effectively suppressed the induction of mRNA for inducible nitric oxide synthase by all 3 proinflammatory stimuli. Results from NF-κB-targeted PCR array analysis showed that flavopiridol suppressed IL-1β induction of a broad range of inflammatory mediator genes (59 of 67 tested). CDK-9 inhibition also suppressed the induction of catabolic genes (matrix metalloproteinase 1 [MMP-1], MMP-3, MMP-9, MMP-13, ADAMTS-4, and ADAMTS-5), but did not affect the basal expression of anabolic genes (COL2A, aggrecan, and cartilage oligomeric matrix protein) and housekeeping genes. Flavopiridol had no apparent short-term cytotoxicity, as assessed by G6PDH activity. Finally, in IL-1β-treated cartilage explants, flavopiridol reduced the release of the matrix degradation product GAG and cleaved COL2A peptides, but did not affect long-term chondrocyte viability.

Conclusion: CDK-9 activity is required for the primary inflammatory response in chondrocytes. Flavopiridol suppresses the induction of inflammatory mediator genes and catabolic genes to protect cartilage from the deleterious effects of proinflammatory cytokines, without affecting cell viability and functions.

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.38378DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4127300PMC

Still can't find the full text of the article?

We can help you send a request to the authors directly.
June 2014
20 Reads
8 Citations

Article Mentions


Provided by Crossref Event Data

Publication Analysis

Top Keywords

inflammatory mediator
12
cdk-9 inhibition
12
effects proinflammatory
12
catabolic genes
12
mediator genes
12
genes
10
matrix degradation
8
suppressed induction
8
inflammatory response
8
proinflammatory stimuli
8
presence absence
8
genes catabolic
8
primary inflammatory
8
cartilage explants
8
anabolic genes
8
gag cleaved
8
catabolic effects
8
inhibition protects
8
protects cartilage
8
proinflammatory cytokines
8

Similar Publications